Is Carisma Therapeutics, Inc. (CARM) a Buy, Sell, or Hold?
OTC : CARM
Carisma Therapeutics, Inc.
$0.0052 USD
$0.0 (-8.77%)
- Volume
- 10.36K
- Average Volume
- 35.4K
- Market Capitalization
- $217.59K
- P/E Ratio
- 0.01
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $0.56
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.86
Insider Activity Summary (Last 12 Months)
Insiders Buying
6
Insiders Selling
5
Amount of Insider Selling
$598.31K
CARM Insider Buying/Selling by Quarter
CARM Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-07 | M-Exempt | 0.11 | 2025-10-08 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-07 | S-Sale | 0.2542 | 2025-10-08 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-07 | M-Exempt | 0.11 | 2025-10-08 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-01 | S-Sale | 0.257 | 2025-10-03 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-02 | S-Sale | 0.2543 | 2025-10-03 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-10-03 | S-Sale | 0.2604 | 2025-10-03 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2025-01-28 | A-Award | 0.5 | 2025-01-30 |
| Kelly Steven | director, officer: President and CEO | 2025-01-28 | A-Award | 0.5 | 2025-01-30 |
| McAndrew Natalie | officer | 2025-01-01 | 0 | 2025-01-02 | |
| Cheng Sohanya Roshan | director | 2024-10-31 | A-Award | 0.97 | 2024-11-01 |
| Cheng Sohanya Roshan | director: | 2024-10-31 | 0 | 2024-11-01 | |
| Thorell Marella | director | 2024-07-01 | A-Award | 1.67 | 2024-07-01 |
| Scadden David | director | 2024-07-01 | A-Award | 1.67 | 2024-07-01 |
| Thorell Marella | director: | 2024-06-30 | 0 | 2024-07-01 | |
| Scadden David | director: | 2024-06-30 | 0 | 2024-07-01 | |
| ZWEIFACH SANFORD S | director | 2024-06-26 | A-Award | 1.22 | 2024-06-27 |
| Morrison Briggs | director | 2024-06-26 | A-Award | 1.22 | 2024-06-27 |
| Hohneker John | director | 2024-06-26 | A-Award | 1.22 | 2024-06-27 |
| Torok Michael | director | 2024-06-26 | A-Award | 1.22 | 2024-06-27 |
| Morris Richard Steven | officer: Chief Financial Officer | 2024-06-17 | A-Award | 1.03 | 2024-06-18 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2024-06-17 | A-Award | 1.03 | 2024-06-18 |
| Kelly Steven | director, officer: President and CEO | 2024-06-17 | A-Award | 1.03 | 2024-06-18 |
| Hohneker John | director | 2024-04-01 | A-Award | 2.09 | 2024-04-01 |
| Hohneker John | director: | 2024-04-01 | 0 | 2024-04-01 | |
| Morris Richard Steven | officer: Chief Financial Officer | 2024-01-31 | A-Award | 2.1 | 2024-02-02 |
| Klichinsky Michael | officer: Chief Scientific Officer | 2024-01-31 | A-Award | 2.1 | 2024-02-02 |
| Kelly Steven | director, officer: President and CEO | 2024-01-31 | A-Award | 2.1 | 2024-02-02 |